Home
About
Overview
Sharing Data
ORCID
Help
History (6)
SARS-CoV-2 and Stroke in a New York Healthcare System.
Testing proposed quality measures for treatment of carpal tunnel syndrome: feasibility, magnitude of quality gaps, and reliability.
The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: associated costs, absences, and objective productivity loss.
Tibial bone stress injury: diagnostic performance and inter-reader agreement of an abbreviated 5-min magnetic resonance protocol.
Effect of subconjunctival bevacizumab on primary pterygium.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effect of subconjunctival bevacizumab on primary pterygium.
Teng CC, Patel NN, Jacobson L. Effect of subconjunctival bevacizumab on primary pterygium. Cornea. 2009 May; 28(4):468-70.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Conjunctiva
Humans
Male
Middle Aged
Pterygium
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Christopher C Teng MD, MBA